NEW YORK (GenomeWeb News) - GVK Biosciences is collaborating with Crelux to offer biopharmaceutical companies an integrated drug discovery and development platform for use in structure-based drug design programs, Hyderabad, India-based GVK Bio said today.

GVK Bio will conduct in silico, in vitro, and in vivo studies and functions related to preclinical candidate nomination, while Munich-based Crelux will perform multifaceted structural studies toward X-ray elucidation of fragment or lead target complexes.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.